Literature DB >> 16007624

Smokeless tobacco use and the risk of Parkinson's disease mortality.

Eilis J O'Reilly1, Marji L McCullough, Ann Chao, S Jane Henley, Eugenia E Calle, Michael J Thun, A Ascherio.   

Abstract

We examined the association between smokeless tobacco use and Parkinson's disease (PD) mortality as assessed by death certificate in a prospective cohort of 95,981 never-smoking men. In this cohort, smokeless tobacco use is inversely associated with PD mortality, with an age-adjusted risk of 0.22 (0.07-0.67) among current users compared to never users. Copyright (c) 2005 Movement Disorder Society.

Entities:  

Mesh：

Year:  2005        PMID： 16007624     DOI： 10.1002/mds.20587

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  24 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 2.  Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease.

Authors:  Amy R Dunn; Kristen M S O'Connell; Catherine C Kaczorowski
Journal:  Neurosci Biobehav Rev       Date:  2019-06-14       Impact factor: 8.989

3.  Dietary nicotine intake and risk of Parkinson disease: a prospective study.

Authors:  Chaoran Ma; Samantha Molsberry; Yanping Li; Michael Schwarzschild; Alberto Ascherio; Xiang Gao
Journal:  Am J Clin Nutr       Date:  2020-10-01       Impact factor: 7.045

Review 4.  Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.

Authors:  Maryka Quik; Danhui Zhang; Matthew McGregor; Tanuja Bordia
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

5.  Epidemiology of Parkinson disease in the city of Kolkata, India: a community-based study.

Authors:  S K Das; A K Misra; B K Ray; A Hazra; M K Ghosal; A Chaudhuri; T Roy; T K Banerjee; D K Raut
Journal:  Neurology       Date:  2010-10-12       Impact factor: 9.910

6.  Temporal relationship between cigarette smoking and risk of Parkinson disease.

Authors:  E L Thacker; E J O'Reilly; M G Weisskopf; H Chen; M A Schwarzschild; M L McCullough; E E Calle; M J Thun; A Ascherio
Journal:  Neurology       Date:  2007-03-06       Impact factor: 9.910

Review 7.  Nicotine and Parkinson's disease: implications for therapy.

Authors:  Maryka Quik; Kathryn O'Leary; Caroline M Tanner
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

8.  Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality.

Authors:  Eilis J O'Reilly; Honglei Chen; Hannah Gardener; Xiang Gao; Michael A Schwarzschild; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2009-01-08       Impact factor: 4.897

Review 9.  Multiple roles for nicotine in Parkinson's disease.

Authors:  Maryka Quik; Luping Z Huang; Neeraja Parameswaran; Tanuja Bordia; Carla Campos; Xiomara A Perez
Journal:  Biochem Pharmacol       Date:  2009-05-09       Impact factor: 5.858

10.  Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions.

Authors:  Yousef Tizabi; Bruk Getachew
Journal:  Clin Pharmacol Transl Med       Date:  2017-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.